Literature DB >> 19330554

Achievement of complete remission of refractory hairy cell leukemia by rituximab progressing after allogeneic hematopoietic stem cell transplantation.

Junichi Kiyasu1, Motoaki Shiratsuchi1, Rie Ohtsuka1, Eriko Sada1, Kensaku Idutsu1, Eriko Nagasawa1, Ryoichi Takayanagi1, Yasunobu Abe2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19330554     DOI： 10.1007/s12185-009-0297-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  6 in total

1.  Complete molecular remission induced by concomitant cladribine--rituximab treatment in a case of multi-resistant hairy cell leukemia.

Authors:  Francesco Forconi; Francesca Toraldo; Elisa Sozzi; Teresa Amato; Donatella Raspadori; Francesco Lauria
Journal:  Leuk Lymphoma       Date:  2007-12

2.  Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience.

Authors:  M S Tallman; D Hakimian; A W Rademaker; C Zanzig; E Wollins; E Rose; L C Peterson
Journal:  Blood       Date:  1996-09-15       Impact factor: 22.113

3.  Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis.

Authors:  P Dreger; R Brand; D Milligan; P Corradini; J Finke; G Lambertenghi Deliliers; R Martino; N Russell; A van Biezen; M Michallet; D Niederwieser
Journal:  Leukemia       Date:  2005-06       Impact factor: 11.528

4.  Treatment of hairy-cell leukemia with chemoradiotherapy and identical-twin bone-marrow transplantation.

Authors:  M A Cheever; A Fefer; P D Greenberg; F Appelbaum; J O Armitage; C D Buckner; G E Sale; R Storb; R P Witherspoon; E D Thomas
Journal:  N Engl J Med       Date:  1982-08-19       Impact factor: 91.245

5.  Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.

Authors:  Jorge Nieva; Kelly Bethel; Alan Saven
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

Review 6.  Advances in the treatment of hairy-cell leukaemia.

Authors:  Ulrich Mey; John Strehl; Marcus Gorschlüter; Carsten Ziske; Axel Glasmacher; Hans Pralle; Ingo Schmidt-Wolf
Journal:  Lancet Oncol       Date:  2003-02       Impact factor: 41.316
  6 in total
  1 in total

1.  Hairy cell leukemia: short review, today's recommendations and outlook.

Authors:  V Maevis; U Mey; G Schmidt-Wolf; I G H Schmidt-Wolf
Journal:  Blood Cancer J       Date:  2014-02-14       Impact factor: 11.037
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.